BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
7/20/2022 7:37:19 AM | Browse: 888 | Download: 1979
 |
Received |
|
2022-02-04 18:41 |
|
Peer-Review Started |
|
2022-02-04 18:43 |
|
First Decision by Editorial Office Director |
|
2022-04-11 07:56 |
|
Return for Revision |
|
2022-04-11 07:56 |
|
Revised |
|
2022-04-26 14:28 |
 |
Publication Fee Transferred |
|
|
|
Second Decision by Editor |
|
2022-07-11 02:52 |
|
Second Decision by Editor-in-Chief |
|
|
|
Final Decision by Editorial Office Director |
|
2022-07-11 18:30 |
|
Articles in Press |
|
2022-07-11 18:30 |
|
Edit the Manuscript by Language Editor |
|
2022-07-08 03:14 |
|
Typeset the Manuscript |
|
2022-07-12 07:19 |
|
Publish the Manuscript Online |
|
2022-07-20 07:37 |
| ISSN |
2222-0682 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ |
| Copyright |
©The Author(s) 2022. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Emergency Medicine |
| Manuscript Type |
Meta-Analysis |
| Article Title |
Pain reduction and adverse effects of intravenous metoclopramide for acute migraine attack: A systematic review and meta-analysis of randomized-controlled trials
|
| Manuscript Source |
Invited Manuscript |
| All Author List |
Nat Ungrungseesopon and Wachira Wongtanasarasin |
| ORCID |
|
| Funding Agency and Grant Number |
|
| Corresponding Author |
Wachira Wongtanasarasin, MD, Attending Doctor, Department of Emergency Medicine, Faculty of Medicine, Chiang Mai University, 110 Intavarorot Street, Sriphum, Chiang Mai 50200, Thailand. wachir_w@hotmail.com |
| Key Words |
Metoclopramide; Migraine; Efficacy; Adverse effect; Randomized controlled trials |
| Core Tip |
Metoclopramide may be used to treat people suffering from acute migraine. However, no comprehensive investigation on this issue has been recorded. We conducted an up-to-date systematic review and meta-analysis of the clinical efficacy of metoclopramide during an acute migraine attack. This study comprised 14 studies and found that metoclopramide was more effective than placebo in treating migraine at the emergency department. When compared to other medications, however, no substantial advantage was detected. More study is needed to enhance migraine therapy in acute care settings effectively. |
| Publish Date |
2022-07-20 07:37 |
| Citation |
Ungrungseesopon N, Wongtanasarasin W. Pain reduction and adverse effects of intravenous metoclopramide for acute migraine attack: A systematic review and meta-analysis of randomized-controlled trials. World J Methodol 2022; 12(4): 319-330
|
| URL |
https://www.wjgnet.com/2222-0682/full/v12/i4/319.htm |
| DOI |
https://dx.doi.org/10.5662/wjm.v12.i4.319 |
Copyright © 1993-2026 Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA. All rights reserved, including rights relating to text and data mining, AI training, and similar technologies. For open-access content, the applicable copyright and licensing terms govern.
